CClinicalTrials.gg
Status unknownNCT02983032Updated Dec 12, 2016

Brief Behavioural Treatment for Insomnia in Dementia Carers

An interventional study of BBTI in Dementia, sponsored by NHS Greater Glasgow and Clyde. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-12-12.

Sponsored by NHS Greater Glasgow and Clyde · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Dec 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Background: between 50-74% of dementia carers report some sleep disturbance. However, relatively few studies have looked at psychological treatment for insomnia in this group. Dementia carers may be particularly at risk for suffering negative consequences from the impact of sleep loss on top of the stress of their carer role. Researchers have found that Brief Behavioural Treatment for Insomnia (BBTI) can be effective for improving symptoms of insomnia in older adults. BBTI focusses on sleep-related behaviour such as napping and when a person gets up and goes to bed.

Aims: this study aims to explore whether delivering group-based, Brief Behavioural Treatment for Insomnia (BBTI) to family carers of people with dementia is feasible, given that, to date, this has not yet been explored.

Who is eligible?: carers with insomnia who care for a family member with dementia and live with them at home are eligible for inclusion in this study.

What is involved for participants?: taking part will involve an initial telephone discussion with a researcher to check suitability. Participants will then meet the researcher for assessment. Assessment includes a sleep interview and completing some questionnaires. Participants will then be required to attend 3 group sessions of BBTI across the space of 4 weeks. After attending the BBTI group, participants will be asked to fill in some of the same questionnaires that they filled in during assessment and again 4 weeks later. Participants will also be invited to take part in a focus group to give feedback about the treatment and their overall experience of being in the study.

Read the detailed description

This study will explore the feasibility of delivering adapted BBTI in a group setting to family carers of people with dementia. The study will be a feasibility study given that delivering BBTI to groups of dementia carers hasn't been done before. It is therefore necessary to explore, in essence, whether it is 'do-able'. In-line with this, the current study will be considering the following:

  • How many eligible participants consent to participate in the study?
  • How many carers stay in the study until the end?
  • Do carers find BBTI an acceptable treatment, are they able to comply with treatment instructions, and what modifications might be required?
  • Are any improvements in sleep observed?
  • Are any improvements in anxiety, depression and carer burden observed? It is hypothesised that carers' sleep will improve over the course of the study. Specifically, it is hypothesised that there will be a reduction in scores on the Pittsburgh Sleep Quality Index (PSQI), an increase in scores on the Sleep Condition Indicator (SCI), and an improvement in sleep diary parameters (increased sleep efficiency, a reduction in sleep latency and a reduction in wake time after sleep onset) following participation in BBTI. Sleep efficiency is calculated by dividing time spent in bed divided by time actually asleep; sleep latency is the time it takes you to fall asleep and reduction in wake time after sleep onset is the total time you are awake during the night after you first fall asleep. Based on a calculation, the sample size required is estimated to be 11. Given that some participants may withdraw from the study the study will aim to recruit 15 participants.

Procedure Individuals who are caring for a family member with dementia will be given a Participant Invitation Letter by healthcare workers and advertisements will be place in relevant clinics. Those interested in finding out more will make contact with the research team, who will screen potential participants. Those meeting the criteria will be sent a Participant Information Sheet and invited to attend a baseline assessment appointment. At the initial assessment appointment, the researcher will answer any questions the person has about the study, the Participant Information Sheet, or the Consent Form. They will then be asked to fill in the Consent Form before starting the assessment. If they do not consent the assessment will not be initiated. If they do consent, then the researcher will proceed to completing the baseline assessment. This will include the semi-structured sleep interview and questions regarding physical and mental health. The following measures will also be administered: Alcohol Use Disorders Identification Test (AUDIT), Drug Use Disorders Identification Test (DUDIT), Pittsburgh Sleep Quality Index (PSQI), Sleep Condition Indicator (SCI), Hospital Anxiety and Depression Scale (HADS) and the Zarit Burden Interview (ZBI).

Participants will also be shown how to complete a sleep diary at this appointment and will be asked to complete this for the two weeks prior to the first session of BBTI. The baseline assessment appointment is expected to last between 45-60 minutes.

The intervention will be delivered across 3 group sessions and 1 telephone consultation over a period of 4 weeks, as follows:

Week 1 - 90 minute group session (allowing time to cover all the educational material and to give individual sleep instructions as well as a break and initial group introductions) Week 2 - Group session (max 45 mins) Week 3 - Phone call (approx. 15 minutes) Week 4 - Final group session (max 45 mins) Week 5 - Appointments for post-treatment assessment

There will be two group facilitators and groups will have a maximum of 5 participants. Participants will be asked to keep sleep diaries throughout the intervention period. At the beginning of each session, participants will also be asked to complete the Stanford Sleepiness Scale in order to monitor daytime sleepiness.

The following measures will be administered post-treatment and at 4 week follow-up: Pittsburgh Sleep Quality Index (PSQI), Sleep Condition Indicator (SCI), Hospital Anxiety and Depression Scale (HADS) and the Zarit Burden Interview (ZBI).

02

Conditions studied

  • Dementia

Keywords

  • Caregivers
  • Insomnia
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

This study's planned enrollment of 15 is below the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

NHS Greater Glasgow and Clyde is the lead sponsor of 215 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Carer of person with dementia
  • Live with person being cared for
  • Meet Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria for insomnia disorder with the exception that carers not meeting the frequency criterion of 3 times per week or duration criterion of 3 months will still be included if frequency is at least twice per week and duration 2 months.
  • competent in English language and have good basic literacy skills.

Exclusion criteria

Exclusion Criteria:

  • unstable, moderate to severe mental health issues (particularly Major Depressive Disorder and Bipolar Disorder)
  • already receiving a psychological intervention
  • untreated sleep disorders eg obstructive sleep apnoea, restless legs syndrome and periodic limb movement disorders.
  • current serious medical condition, such as cancer or recent remission from cancer
  • learning disability or a neurological condition (e.g. Multiple Sclerosis, Parkinson's disease, epilepsy)
  • being investigated for or existing diagnosis of degenerative condition
  • sleep problem primarily due to having to be awake during the night/early morning to respond to the needs of the person they care for
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Brief behavioural treatment for insomnia (BBTI)

    A behavioural therapy for improving symptoms of insomnia in older adults focussing on sleep-related behaviour such as napping and when a person gets up and goes to bed.

    Behavioral: BBTI

Interventions

  • BehavioralBBTI

    3 group sessions over 4 weeks

06

What researchers measure

Primary outcomes

  1. Sleep quality

    Change in Pittsburgh Sleep Quality Index (PSQI) score

    Time frame: Baseline and four weeks post-intervention

Secondary outcomes

  1. Sleep condition

    Change in score from Sleep Condition Indicator (SCI)

    Time frame: Baseline and four weeks post-intervention

  2. Anxiety

    Change in score from Hospital Anxiety and Depression Scale (HADS)

    Time frame: Baseline and four weeks post-intervention

  3. Burden

    Change in score from the Zarit Burden Interview (ZBI)

    Time frame: Baseline and four weeks post-intervention

  4. Sleep efficiency

    Change in sleep efficiency (calculated by dividing time spent in bed by time actually asleep)

    Time frame: Baseline and four weeks post-intervention

  5. Sleep latency

    Change in sleep latency (the time taken to fall asleep)

    Time frame: Baseline and four weeks post-intervention

  6. Wake time after sleep onset

    Change in total time you are awake during the night after you first fall asleep

    Time frame: Baseline and four weeks post-intervention

07

Study locations

1 site
  • NHS Greater Glasgow and Clyde
    Glasgow, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02983032
Lead sponsor
NHS Greater Glasgow and Clyde
Collaborators
University of Glasgow
Responsible party
Sponsor
First posted
Dec 6, 2016
Start date
Jan 2017
Primary completion
Sep 2017 (estimated)
Completion
Sep 2017 (estimated)
Last update
Dec 12, 2016

Study contacts

Rosie Begbie, MA (Hons)
Contact
k.begbie.1@research.gla.ac.uk
Maria Gardani, PhD
Contact
maria.gardani@glasgow.ac.uk
Maria Gardani, PhD
principal investigator · University of Glasgow

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion